---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-041985"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:06:48.464939+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Strata Skin Sciences Q3 revenue $6.9M (-21% YoY); net loss narrows to $1.6M

## Summary
- Revenue $6.9M (-21% YoY); net loss $1.6M (EPS -$0.36) vs $2.1M loss (EPS -$0.51) last year.
- Global recurring revenue $5.5M (+3% YoY); equipment revenue $1.4M (-60%).
- EBITDA slightly positive vs -$0.2M; cash $7.1M after $2.4M registered direct offering.
- CMS recognized expanded CPT codes for XTRAC; COFEPRIS cleared TheraClearX in Mexico.
- XTRAC install base 838 (-6); TheraClearX 161; avg gross billings per device $5,981 (+8.5%).

## SEC filing metadata
- accession: 0001140361-25-041985
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036125041985/0001140361-25-041985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036125041985/ef20058935_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-041985
- JSON: https://secwatch.observer/filing/0001140361-25-041985.json
- Plain text: https://secwatch.observer/filing/0001140361-25-041985.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.